Completed
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine
NCT00133146
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +1 more
- Locations
-
- Allied Research International Inc. Mississauga, Ontario, Canada